Livent (LTHM) Now Covered by Analysts at HSBC

HSBC started coverage on shares of Livent (NASDAQ:LTHM) in a research note issued to investors on Monday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $22.00 target price on the stock.

Several other equities analysts have also commented on LTHM. Buckingham Research assumed coverage on shares of Livent in a report on Wednesday, November 14th. They issued a neutral rating and a $18.00 target price on the stock. They noted that the move was a valuation call. Loop Capital assumed coverage on shares of Livent in a report on Friday, November 9th. They issued a buy rating and a $22.00 target price on the stock. Bank of America assumed coverage on shares of Livent in a report on Monday, November 5th. They issued a buy rating and a $20.00 target price on the stock. Credit Suisse Group assumed coverage on shares of Livent in a report on Monday, November 5th. They issued an outperform rating and a $20.00 target price on the stock. Finally, Goldman Sachs Group assumed coverage on shares of Livent in a report on Monday, November 5th. They issued a buy rating and a $22.00 target price on the stock. Two research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus target price of $20.20.

LTHM stock opened at $17.26 on Monday. Livent has a 12 month low of $14.00 and a 12 month high of $19.90.

Livent (NASDAQ:LTHM) last released its earnings results on Tuesday, November 6th. The company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.21 by $0.04. The firm had revenue of $112.00 million during the quarter, compared to the consensus estimate of $113.40 million.

About Livent

Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries.

Further Reading: What are Institutional Investors?

Analyst Recommendations for Livent (NASDAQ:LTHM)

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply